( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas

, , , , , , , , , , , , , , и . British journal of haematology, 142 (5): 732–744 (2008)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Marita Ziepert

Manfred Ziepert

Maria Ziepert

Marita Allerbeck

Marita Traenckner

 

Другие публикации лиц с тем же именем

Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia, , , , , , , , , и 3 other автор(ы). Blood, 117 (10): 2918–2923 (2011)KMWin--a convenient tool for graphical presentation of results from Kaplan-Meier survival time analysis, , и . PloS one, 7 (6): e38960 (2012)Histopathological diagnosis of graft-versus-host disease of the skin--an interobserver comparison, , , , , , , и . Journal of the European Academy of Dermatology and Venereology : JEADV, 28 (7): 915–924 (2014)Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma, , , , , , , , , и 1 other автор(ы). Clinical cancer research : an official journal of the American Association for Cancer Research, 18 (13): 3637–3647 (2012)High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma, , , , , , , , , и . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21 (11): 2255–2261 (2010)High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), , , , , , , , и . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 20 (12): 1977–1984 (2009)CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial, , , , , , , , , и . Annals of hematology, 92 (11): 1521–1528 (2013)Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone), , , , , , , , , и 2 other автор(ы). Annals of hematology, 87 (9): 717–726 (2008)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , и 10 other автор(ы). Blood, 121 (12): 2253–2263 (2013)Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era, , , , , , и . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (14): 2373–2380 (2010)